PFCS
LRMR icon

Pale Fire Capital SE’s Larimar Therapeutics LRMR Stock Holding History

Pale Fire Capital SE’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45,218
Closed -$172K – 70
2025
Q4 		$172K Hold
45,218
– – 0.01% 54
2025
Q3 		$146K Buy
45,218
+7,700
+21% +$28.9K 0.02% 48
2025
Q2 		$108K Hold
37,518
– – 0.01% 56
2025
Q1 		$80.7K Buy
37,518
+5,209
+16% +$16.5K 0.01% 51
2024
Q4 		$125K Hold
32,309
– – 0.03% 40
2024
Q3 		$212K Buy
32,309
+18,017
+126% +$145K 0.03% 41
2024
Q2 		$104K Buy
+14,292
New +$109K 0.01% 37
2024
Q1 		– Sell
-12,040
Closed -$54.8K – 70
2023
Q4 		$54.8K Hold
12,040
– – 0.01% 70
2023
Q3 		$47.6K Buy
+12,040
New +$45.5K ﹤0.01% 68

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Pale Fire Capital SE's LRMR Position: Q1 2026 in Review

Pale Fire Capital SE sold out of Larimar Therapeutics (LRMR) in Q1 2026, closing a stake of 45,218 shares — an estimated $172K sold.

Pale Fire Capital SE first reported a position in LRMR in Q3 2023 and held it in 9 quarters. The position peaked at $212K in Q3 2024. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Pale Fire Capital SE reported no remaining Larimar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Pale Fire Capital SE sold 45,218 Larimar Therapeutics shares in Q1 2026, an estimated $172K.
  • Pale Fire Capital SE first reported a position in Larimar Therapeutics in Q3 2023 and held it in 9 quarters.
  • Pale Fire Capital SE's Larimar Therapeutics position peaked at $212K in Q3 2024.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Pale Fire Capital SE's 13F filing for Q1 2026, filed 14 May 2026.